IDEXX estima receita 2026 de US$4,741‑4,767B e lucro de US$14,96‑15,16; CoVet adiciona US$ 5 milhões

IDEXX Q3 2026 earnings: raised revenue and EPS outlook, strong diagnostics growth, and CoVet AI expansion.